Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Fulgent Genetics, Inc. (FLGT)

Fulgent Genetics Q3 revenue rises 8% to $90.4 million; loss widens to $0.48 per share

Mixed Impact 3 of 5 earnings Written later

Fulgent Genetics reported third quarter 2026 revenue of $90.4 million, up about 8% from a year earlier, but swung to a GAAP loss of $13.2 million, or $(0.48) per share, from a loss of $(0.21) per share a year earlier. The company kept its full-year revenue guidance of $330.0-$340.0 million and improved its outlook for the full-year non-GAAP loss and cash, which it attributed to disciplined spending; the CFO also cited progress on a billing system issue. For shareholders, revenue growth is offset by larger losses in the quarter.

Key points

  • Q3 2026 revenue of $90.4 million versus $84.1 million a year earlier; GAAP loss of $13.2 million, or $(0.48) per share, versus $(0.21) per share
  • Non-GAAP loss of $2.4 million, or $(0.09) per share, compared with non-GAAP income of $4.5 million, or $0.15 per share, in Q3 2025
  • Full-year 2026 revenue guidance maintained at $330.0-$340.0 million; non-GAAP loss guidance set at approximately $46.0-$50.0 million
  • Cash, cash equivalents, restricted cash and marketable securities totaled $652.4 million at September 30, 2026

The filing

CompanyFulgent Genetics, Inc. (FLGT)
Form8-K, current report
Filed with the SECNov 5, 2026, 4:08 PM ET
Accession number0001193125-26-449799

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:53 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 05, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.